PT UBC Medical Indonesia Tbk (ISX:LABS) Selling, General, & Admin. Expense: Rp Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT UBC Medical Indonesia Tbk Selling, General, & Admin. Expense?

PT UBC Medical Indonesia Tbk ISX:LABS -2.30% Selling, General, & Admin. Expense is Rp Mil as of . 20. The stock has 2 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. PT UBC Medical Indonesia Tbk's selling, general, & admin. expense for the six months ended in . 20 was Rp0.00 Mil. PT UBC Medical Indonesia Tbk does not have enough years/quarters to calculate its selling, general, & admin. expense for the trailing twelve months (TTM) ended in . 20.


PT UBC Medical Indonesia Tbk  (ISX:LABS) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


PT UBC Medical Indonesia Tbk Selling, General, & Admin. Expense Related Terms


PT UBC Medical Indonesia Tbk Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk Selling, General, & Admin. Expense Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
Selling, General, & Admin. Expense

PT UBC Medical Indonesia Tbk Semi-Annual Data
Selling, General, & Admin. Expense

ISX:LABS vs ABT, SYK, MDT: Selling, General, & Admin. Expense Comparison

For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT UBC Medical Indonesia Tbk Selling, General, & Admin. Expense vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where PT UBC Medical Indonesia Tbk's Selling, General, & Admin. Expense falls into.



PT UBC Medical Indonesia Tbk Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

What does a Selling, General, & Admin. Expense of Rp Mil mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a Selling, General, & Admin. Expense of Rp Mil as of . 20. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on PT UBC Medical Indonesia Tbk and its competitors.
Is PT UBC Medical Indonesia Tbk's Selling, General, & Admin. Expense too high?
PT UBC Medical Indonesia Tbk's current Selling, General, & Admin. Expense is Rp Mil.
How does PT UBC Medical Indonesia Tbk's Selling, General, & Admin. Expense compare to ABT and SYK?
PT UBC Medical Indonesia Tbk's Selling, General, & Admin. Expense of Rp Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Medical Devices & Instruments company?
A good Selling, General, & Admin. Expense depends on the Medical Devices & Instruments industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on PT UBC Medical Indonesia Tbk and its competitors. PT UBC Medical Indonesia Tbk's current Selling, General, & Admin. Expense is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current Selling, General, & Admin. Expense of Rp Mil. The current Selling, General, & Admin. Expense is Rp Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current Selling, General, & Admin. Expense is Rp Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.